C 21 H 16 N 2 O 2 , monoclinic, P21/n (no. 14), a = 13.4768 (7) 
T = 100 K.
CCDC no.: 1474776
The asymmetric unit of the title crystal structure is shown in the gure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters. 
Source of material
A mixture of 7-methoxy-2-naphthol (0.01 mol), malononitrile (0.01 mol), benzaldehyde (0.01 mol), ethanol (30 mL) and piperidine (0.5 mL) was heated under re ux for 1 h. After complete precipitation occurred the solid product was collected by ltration, washed by methanol and recrystallized from ethanol to give the title compound as colourless crystals; yield 89%; M.p.: 528-529 K.
Experimental details
Carbon-bound hydrogen atoms were placed in calculated positions and were included in the re nement in the riding model approximation. The H atoms of the methyl groups were allowed to rotate with a xed angle around the C-C bond to best t the experimental electron density. .
Discussion
Chromene and benzochromene derivatives have attracted considerable interest owing to their biological and pharmaceutical activities such as antibacterial [1] [2] [3] , antifungal [4] [5] [6] , vascular-disrupting [7] , antioxidant [8, 9] , anticancer [10] [11] [12] [13] , estrogenic anticoagulant and antispasmolytic [14] , antileishmanial [15] , antiproliferative and apoptosis inducing [16] [17] [18] [19] .
In the title structure the asymmetric unit contains one independent molecule. All bond lengths and angles are in the expected ranges. The phenyl ring (C16-C20) is perpendicular to the plane of the rest of the molecule (84°). The molecules are connected in the crystal structure via two symmetry related strong classical intermolecular hydrogen bonds, N1-H2N1· · · N2 
